Alzheimer's Association International Conference (AAIC) 2025
Congress Details
July 27-31, 2025
Toronto, Canada
The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.
All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.
For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.
Image
Congress Materials
Image
Presentation Type
Poster
Image
Location
Toronto, Canada
Image
Title
Identifying and Characterizing Comorbid Cerebral Amyloid Angiopathy in ADNI Participants using Boston Criteria Version 2.0
Identifying and Characterizing Comorbid Cerebral Amyloid Angiopathy in ADNI Participants using Boston Criteria Version 2.0
Small Interfering RNA Targeting Amyloid-Beta Precursor Protein Reduces Alzheimer’s Disease Pathology in 5xFAD Mice and Abrogates Behavior Changes in Early Intervention Paradigm
Small Interfering RNA Targeting Amyloid-Beta Precursor Protein Reduces Alzheimer’s Disease Pathology in 5xFAD Mice and Abrogates Behavior Changes in Early Intervention Paradigm
Multiple-Dose Results from an Ongoing Phase 1 Study of Mivelsiran, an Investigational RNA Interference Therapeutic Targeting Amyloid-Beta Precursor Protein for Alzheimer’s Disease
Multiple-Dose Results from an Ongoing Phase 1 Study of Mivelsiran, an Investigational RNA Interference Therapeutic Targeting Amyloid-Beta Precursor Protein for Alzheimer’s Disease
RNAiScience Data Hall is for healthcare professionals. By creating an account, you will have access to:
- All RNAi on-demand educational content - Personalization experience with ability to bookmark content for future reference
Image
* Required Fields
Image
Forgot password? Please enter the email address that is registered with the RNAiScience Data Hall.
Image
Forgot password
* Required Fields
Navigating to third party website
You are now leaving this site and being directed to a third-party website that is not maintained by Alnylam. Alnylam does not endorse and is not responsible for content or maintenance of third-party websites.
Navigating to another Alnylam website
You are now leaving this site and being directed to another Alnylam website.
Share this resource
OR
Warning !
All you changes will be discarded. Would you like to continue and collapse the section?
Confirmation !
Would you like to go ahead and update your preferences ?
Update Password
This search function is intended exclusively for healthcare professionals to support scientific exchange and to communicate educational material. By searching, you confirm that your query is unsolicited. Results may include information about prescription‑only medicines, investigational products, or uses not approved in your country. For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.
Sign in to bookmark information and create your personal library
This global site is intended for healthcare professionals only to support scientific exchange.
This website is not country-specific and may contain information about prescription medicines, investigational medicinal products, and uses that are not approved in or may not be applicable to your country.
This global website is intended for healthcare professionals outside Argentina, Australia, Brazil, Colombia, KSA, Mexico, Qatar, Taiwan, UAE, and the UK.
This site is not intended to provide medical advice or recommendations for clinical practice. Please refer to regulatory approved product information in your country for any medicinal products mentioned on this website. Information about investigational medicinal products or investigational uses of approved products does not establish the safety or efficacy of these medicinal products or uses and does not guarantee regulatory approval in any country. Alnylam does not recommend or suggest the use of its products in any manner inconsistent with the regulatory approved product Information.
Alnylam disclaims liability for the accuracy, completeness, or use of information on this website, and any obligation to update the information contained on this website.
By accessing this website, you accept this legal disclaimer and you expressly confirm your status as a healthcare professional and agree not to share this content with the public.
This site may include information about specific medicinal products or ongoing clinical research for the sole purpose of facilitating scientific exchange with healthcare professionals. It may include investigational uses or information not approved in your country.